Breast Flashcards
Fibroadenomas: common in women who are what age
> 3cm should be:
Any increased risk of malignancy?
<30 yrs
Excision core biopsied to exclude phyllodes tumour
No
“Halo” appearance on breast US
Breast cyst
Tamoxifen:
Used in:
Adverse effects:
Oestrogen receptor positve breast cancer
Menstrual disturbance: Vaginal bleeding, amenorrhoea
Hot flushes
VTE
Endometrial cancer (increased risk)
Aromatase inhibitors adverse effects:
OSTEOPOROSIS (DEXA before initiating tx.)
Hot flushes
Arthralgia
Insomnia
Duct papilloma:
Presents with:
Treatment:
Nipple discharge
Mircodochectomy
Most common type of breast cancer:
Invasive ductal carcinomas
Characteristics of tumour for mastectomy:
Central multifocal Large lesion in small breast DCIS >4cm Patient choice
Breast cancer prognostic tool:
Nottingham prognostic index:
Most breast cancers are treated surgically:
If no palpable axillary lymphadenopathy:
If palpable axillary lymphadenopathy:
Pre-operative US should be done before surgery and if positive a sentinel node biopsy should be taken.
Axillary node clearance at primary surgery
Axillary node clearance complications:
Lymphoedema of the arm and functional impairment
Women who undergo WLE for breast cancer or Mastectomy for T3/4 tumours or with 4+ axillary lymphnodes should receive:
Radiotherapy
Hormonal therapy:
given if:
Pre/peri menopausal women:
Post menopausal women
Hormone receptor positive
Tamoxfien
Aromatase inhibitor (As this would INDUCE menopause in a pre-menopausal woman)
HER2 positive breast tumour biologic:
Herceptin (Trastuzumab)
Urgent referral for Breast cancer assessment if:
CONSIDER urgent regerral if:
Aged 30 or over w/ unexplained breast lump
Aged 50 or over with unilateral symptoms of discharge or retraction
Skin changes that suggest breast cancer
Aged 30 or over with an unexplained lump in axilla
Breast cancer risk factors:
Nulliparity
Late first pregnancy (<30 years)
Early menarche, late menopause (oestrogen exposure)
Obesity